celecoxib has been researched along with MS (Multiple Sclerosis) in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Celecoxib is a selective cyclooxygenase-2 (COX2) inhibitor." | 5.39 | A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. ( Alloza, I; Chiba, A; Di Penta, A; Miyake, S; Vandenbroeck, K; Villoslada, P; Wyssenbach, A; Yamamura, T, 2013) |
"The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod." | 5.38 | A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012) |
"Celecoxib is a selective cyclooxygenase-2 (COX2) inhibitor." | 1.39 | A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. ( Alloza, I; Chiba, A; Di Penta, A; Miyake, S; Vandenbroeck, K; Villoslada, P; Wyssenbach, A; Yamamura, T, 2013) |
"The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod." | 1.38 | A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Penta, A | 1 |
Chiba, A | 1 |
Alloza, I | 1 |
Wyssenbach, A | 1 |
Yamamura, T | 1 |
Villoslada, P | 1 |
Miyake, S | 1 |
Vandenbroeck, K | 1 |
Cocco, G | 1 |
2 other studies available for celecoxib and MS (Multiple Sclerosis)
Article | Year |
---|---|
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.
Topics: Animals; Astrocytes; Axons; Celecoxib; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Cytokines; Dise | 2013 |
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?
Topics: Arthritis, Psoriatic; Atrial Fibrillation; Autoimmune Diseases; Celecoxib; Cyclooxygenase Inhibitors | 2012 |